Investigators
Open Research Studies for Other Motility Research
Indiana University GI Neuromuscular Pathology Prospective Registry
Enrolling: Yes
Principle Investigator: John M. Wo, MD
Duration: 2 years
Primary Outcomes Measured:
- Follow up clinical data will be obtained before, 6 months, 1.5 years, and 2 years after the full thickness biopsy
- Follow up data PAGI_SYM Overall Treatment Effect by Patient Overall Treatment Effect by Physician
Secondary Outcomes Measured:
- Responders will be defined as >50% improvement of the GCSI total score at 6 month after surgical GES.
- Patients with gastroparesis from type 1 DM versus patients with idiopathic gastroparesis.
- Patients with gastroparesis from type 1 DM versus gastroparesis from type 2 DM.
- Neuromuscular pathology results of the gastric body and proximal jejunum will be correlated with the following: Symptom severity (GCSI total score), predominant symptom presentation, severity of delayed gastric emptying.
Interested in this study? Please contact the coordinator below:
Maureen Schilling
maschi@iu.edu
GI Motility Diagnosis Registry
Enrolling: Yes
Principle Investigator: John M. Wo, MD
Duration: TBD
Primary Outcomes Measured: Identification of patients by accurate motility diagnosis.
Secondary Outcomes Measured:
- To develop Patient Reported Outcome (PRO) measurements in patients with small intestinal bacterial overgrowth (SIBO)
- To develop Patient Reported Outcome (PRO) measurements in patients with gastroparesis
Interested in this study? Please contact the coordinator below:
Maureen Schilling
maschi@iu.edu
Effect of Transcutaneous Auricular Vagus Nerve Stimulation (taVNS) on Plasma Insulin Levels
Enrolling: Yes
Principle Investigator: Thomas Nowak, MD
Duration: 1 visit.
Primary Outcome Measured:
- The purpose of this study is to evaluate whether electrically stimulating the nerve around the external ear will also stimulate the internal vagus nerve and influence the levels of substances in your body related to insulin production.
Interested in this study? Please contact the coordinator below:
Maureen Schilling
maschi@iu.edu
Closed Research Studies for Other Motility Research
Enrolling: No
Principle Investigator: Akira Saito, MD
Duration: Recruiting 50 patients based in the US.
Primary Outcomes Measured:
- Develop a de novo CIPO-specific PRO that is able to capture change in core CIPO visible signs and symptoms across all etiologies and severity levels.
- Develop a de novo CIPO-specific PRO that is fit-for-purpose for use as a primary endpoint in a clinical trial setting.